Shopping Cart (0)
My Account

Your Shopping Cart
Metabomeeting 2014Drug Discovery India 2014Enabling Genomic Technologies and Screening Asia 2014Drug Metabolism & Discovery ADMETIndian Lab Automation20% Discount OfferePoster Award PrizeBlogs

Epigenetic and MicroRNA Biomarkers 2013 Market Report

Publisher: Select Biosciences
Published: July 2013
Pages: 118 PowerPoint plus Supporting Files in Excel and PDF Formats

Price:



This market report from SELECTBIO represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA research fields.

The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic.  However, these biomarker fields are evolving in parallel with the research marketplace, and therefore SELECTBIO has in this market report characterized the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.

Specific Topics Addressed in this Market Report:

  • Epigenetics Research Market Analysis
    • Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
    • Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
    • Segmentation of Epigenetics Research Activity based on Disease Classes Studied
    • Epigenetics Research Activity in Cancer--Quantitative Segmentation
    • Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]
  • Epigenetics Biomarkers
    • En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
    • Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]
  • MicroRNA Research Market Analysis
    • Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
    • Methodologies and Market Breakout for Expression Profiling
    • Quantitative Breakout of the microRNA Research Market Across the Research Workflow
    • Product Vendors and their Quantitative Penetrance in the microRNA Research Markets
  • MicroRNA Biomarkers Analysis
    • Expression Patterns/Signatures of microRNAs in Different Disease States
    • Prognostic/Diagnostic Potential of microRNA Expression Patterns
    • microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance
  • Cancer Biomarker Classes
    • Traditional Cancer Biomarkers
    • Oncogenes
    • Tumor-Suppressor Genes
  • Companion Diagnostics (CDx)
    • Up-to-date List of CDx on the Marketplace
    • Partnerships in the CDx Space

This Report is written in PowerPoint and is delivered to customers in this format enabling convenient drag-and-drop into R&D Presentations, Business Plans, Investor Presentations.  Associated files that constitute the complete report package are in Excel and PDF formats.

Report Table of Contents (TOC) [Click Here to Download PDF File]

Sample Pages from the Market Report [Downloadable PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Lunchtime Workshop
Lunchtime Workshop
Complementary NMR and MS solutions to solve the “Metabolomics puzzle” Workshop


Keynote Speakers Confirmed, Carlos Caldas and Mark Caulfield
We are thrilled to announce that Professor Carlos Caldas, Group Leader at the Cancer Research UK Cambridge Institute and Professor Mark Caufield, Chief Scientist of the Genomics England 100,000 project, have both confirmed their keynote presentations at Personalized Medicine in May 2015, Cambridge.


Complimentary tour of the GIS High Throughput Cellular Biology Centre in conjunction with Enabling Genomic Technologies & Screening Asia
Complimentary tour of the GIS High Throughput Cellular Biology Centre in conjunction with Enabling Genomic Technologies & Screening Asia
In addition to the comprehensive conference programme, we will also be offering a tour of the facilities at the GIS High Throughput Cellular Biology Centre. The tour is open to all conference attendees, providing you with a detailed insight into the advanced work carried out by the Genome Institute of Singapore.


LAB-ON-A-CHIP ASIA - EARLY BIRD
SAVE UP TO S$ 255 - EARLY BIRD DEADLINE 10 OCTOBER 2014!


Accreditation
“The Medical Association of Saxony certificates the two-day congress with 16 continuing education points.”


Site Visit to the SIMTech Microfluidics Foundry
Site Visit to the SIMTech Microfluidics Foundry
Take advantage of a tour of the facilities at the SIMTech Microfluidic Foundry. Dr. Zhiping Wang, Director of Research Programmes, will be your host, providing all attendees with a detailed insight into the advanced work carried out by SIMTech. Don't miss out - Register today!

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com